{"id":984972,"title":"DSEN Abstract: High potency statins and the risk of new diabetes - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-23","captureTimestamp":"2026-02-23T22:17:30.674000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/49225.html","snippet":"DSEN Abstract High potency statins and the risk of new diabetes This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Colin R. Dormuth, Kristian B. Filion, J. Michael Paterson, Matthew T. James, Gary F. Teare,…","rawSnapshotUrl":"/api/snapshots/raw/984972","browseUrl":"https://replay.healtharchive.ca/job-8/20260223221730/https://cihr-irsc.gc.ca/e/49225.html#ha_snapshot=984972","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}